Development of a novel multi-penicillin assay and assessment of the impact of analyte degradation: lessons for scavenged sampling in antimicrobial pharmacokinetic study design. by Kipper, K et al.
Antimicrobial Agents and Chemotherapy 
Development of a novel multi-penicillin assay and assessment of the impact of analyte 
degradation: lessons for scavenged sampling in antimicrobial pharmacokinetic study design 
  
Karin Kippera,b,c,#, Charlotte I.S. Barkera,d,e, Joseph F. Standinga,d, Mike Sharlanda,e, Atholl 
Johnstonc,f 
Paediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George's 
University of London, London, United Kingdoma; University of Tartu, Institute of Chemistry, 
Tartu, Estoniab; Analytical Services International, St George’s University of London, London, 
United Kingdomc; Inflammation, Infection and Rheumatology Section, UCL Great Ormond Street 
Institute of Child Health, London, United Kingdomd; St George’s University Hospitals NHS 
Foundation Trust, London, United Kingdome; Clinical Pharmacology, Barts and The London 
School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdomf 
 
#Address correspondence to Karin Kipper, karin.kipper@gmail.com. 
Running Head: Issues on beta-lactam scavenged sampling.  
Supplementary data 
  
Carry-over  
The extent of the auto-sampler carry-over was evaluated by injecting the prepared ULOQ (upper 
limit of quantification) calibrator with the concentration 200 mg/L, the extracted blank matrix 
sample and the LLOQ (lower limit of quantification) calibrator with the concentration of 0.1 mg/L. 
Carry-over (signal in the blank sample after ULOQ sample compared with the LLOQ sample) for 
amoxicillin was 0.03 %, for ampicillin 0.32%, for penicillin G and piperacillin 0.38% and for 
flucloxacillin 4.64%. Carry-over for the IS was 2.1%. Carry-over was considered acceptable for 
all analytes and the IS.  
 
Matrix effect 
Matrix effects were determined for amoxicillin, ampicillin, penicillin G, piperacillin and 
flucloxacillin using pre- and post-extraction spike and standard solutions. Penicillins were tested 
over the calibration concentration range and the matrix influence was evaluated. Peak area 
measurements obtained from post-extraction plasma spiked with ampicillin, amoxicillin, penicillin 
G, piperacillin and flucloxacillin at the same concentrations as the calibration range samples were 
compared to the peak area measurements obtained from the standard solutions. The matrix effect 
in 6 plasmas was 96-101.2% for amoxicillin, 98.3-102.1% for ampicillin, 97.5-104.8% for 
penicillin G, 98.3-107.6 for piperacillin, and 96.5-106.7% for flucloxacillin 
 
Dilution integrity 
The accuracy and precision of the diluted QCs after including the 
dilution factor were within the 15% limit. 
